Other limitations derived from the particular characteristics of the SNHDD not yet commented include the following: (1) As only those conditions or treatments that have induced the use of additional therapeutic or diagnosis procedures or negatively affected the LOHS or the IHM have to be recorded [24], the codes for insulin (ICD10 code Z79.4) or other antidiabetic medication use (ICD10 code Z79.84), which are part of the T2DM patient’s treatment and presumably don’t affect the procedures or outcomes of the hospitalization, are not codified among T2DM patients. This evidence concerns the gene INS and type 2 diabetes mellitus.